Mackenzie Financial’s Novartis NVS Stock Holding History

Mackenzie Financial’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,000	Closed	-$261K	–	1134
2019 Q3	$261K	Buy	+3,000	New	+$269K	﹤0.01%	915
2019 Q2	–	Sell	-2,790	Closed	-$211K	–	1208
2019 Q1	$211K	Buy	+2,790	New	+$224K	﹤0.01%	1164
2018 Q3	–	Sell	-33,917	Closed	-$2.3M	–	1136
2018 Q2	$2.3M	Hold	33,917	–	–	0.01%	578
2018 Q1	$2.46M	Buy	33,917 +24,785	+271%	+$1.89M	0.01%	538
2017 Q4	$687K	Buy	9,132 +2,154	+31%	+$163K	﹤0.01%	647
2017 Q3	$537K	Sell	6,978 -13	-0.2%	-$982	﹤0.01%	512
2017 Q2	$523K	Buy	+6,991	New	+$495K	﹤0.01%	514
2016 Q3	–	Sell	-119,043	Closed	-$8.8M	–	804
2016 Q2	$8.8M	Buy	119,043 +1,340	+1%	+$92.6K	0.05%	264
2016 Q1	$7.64M	Buy	117,703 +54,164	+85%	+$3.68M	0.07%	227
2015 Q4	$4.9M	Buy	63,539 +2,551	+4%	+$203K	0.03%	313
2015 Q3	$5.02M	Hold	60,988	–	–	0.03%	291
2015 Q2	$5.37M	Sell	60,988 -2,880	-5%	-$264K	0.03%	301
2015 Q1	$5.64M	Sell	63,868 -6,561	-9%	-$582K	0.03%	307
2014 Q4	$5.85M	Buy	70,429 +1,697	+2%	+$141K	0.03%	305
2014 Q3	$5.8M	Buy	68,732 +1,809	+3%	+$146K	0.03%	305
2014 Q2	$5.43M	Buy	66,923 +11,116	+20%	+$874K	0.03%	323
2014 Q1	$4.25M	Buy	55,807 +8,013	+17%	+$584K	0.02%	333
2013 Q4	$3.44M	Sell	47,794 -1,759	-4%	-$122K	0.02%	335
2013 Q3	$3.41M	Buy	49,553 +1,113	+2%	+$73.6K	0.02%	331
2013 Q2	$3.07M	Buy	+48,440	New	+$3.15M	0.01%	351

Other funds holding NVS

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

Mackenzie Financial's NVS Position: Q4 2019 in Review

Mackenzie Financial sold out of Novartis (NVS) in Q4 2019, closing a stake of 3,000 shares — an estimated $261K sold.

Mackenzie Financial first reported a position in NVS in Q2 2013 and held it in 20 quarters. The position peaked at $8.8M in Q2 2016. 1,173 funds tracked by Wall St. Rank hold NVS as of Q4 2019.

Mackenzie Financial reported no remaining Novartis position as of Q4 2019 after selling out during the quarter.
Mackenzie Financial sold 3,000 Novartis shares in Q4 2019, an estimated $261K.
Mackenzie Financial first reported a position in Novartis in Q2 2013 and held it in 20 quarters.
Mackenzie Financial's Novartis position peaked at $8.8M in Q2 2016.
1,173 funds tracked by Wall St. Rank held Novartis as of Q4 2019.

Based on Mackenzie Financial's 13F filing for Q4 2019, filed 13 Feb 2020.